Cruz announces that investors with losses related to Organon & Co. ("Organon" or the "Company") (NYSE: OGN) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN ...

Organon & Co. (NYSE:OGN), a prominent player in the healthcare sector, has been garnering attention from analysts due to its diverse product portfolio and strategic market positioning. The company ...

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the ...

THE LAWSUIT: A class action securities lawsuit was filed against Organon & Co. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between October 31, ...

On Thursday, BNP Paribas (OTC: BNPQY) Exane adjusted its outlook on Organon & Co. (NYSE: OGN), reducing the price target to $16 from the previous $29, while retaining an Outperform rating on the ...

Notably, defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend.

SAN DIEGO, May 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks ...

Investors have until July 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf ...

Access our full analysis report here, it’s free. Branded Pharmaceuticals company Organon (NYSE:OGN) jumped 5.8%. Is now the time to buy Organon? Access our full analysis report here, it’s free.

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial ...

On May 1, 2025, Organon released its first quarter 2025 financial results, announcing that management had reset the Company’s dividend payout, from $0.28 to $0.02 and would “redirect those ...